Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides

Research output: Contribution to journalJournal article – Annual report year: 2019Researchpeer-review

View graph of relations

Gene therapy is an exciting field that has the potential to address emerging scientific and therapeutic tasks. RNA-based gene therapy has made remarkable progress in recent decades. Nevertheless, efficient targeted delivery of RNA therapeutics is still a prerequisite for entering the clinics. In this review, we introduce current delivery methods for RNA gene therapeutics based on lipid nanoparticles (LNPs). We focus on the clinical appeal of recent RNA NPs and discuss existing challenges of fabrication and screening LNP candidates for effective translation into drugs of human metabolic diseases and cancer.
Original languageEnglish
JournalMolecular Pharmaceutics
Issue number6
Pages (from-to)2265-2277
Number of pages13
Publication statusPublished - 2019
CitationsWeb of Science® Times Cited: No match on DOI

    Research areas

  • Gene therapy, RNA, Delivery, Lipid nanoparticle (LNP), LNP fabrication, LNP screening

ID: 179023328